DSIJ Mindshare

5:1 stock split & 25,000 per cent returns: Multibagger micro-cap stock hit 20 per cent upper circuit on February 19 – scrip trades at high ROE and high ROCE
Kiran Shroff

5:1 stock split & 25,000 per cent returns: Multibagger micro-cap stock hit 20 per cent upper circuit on February 19 – scrip trades at high ROE and high ROCE

The stock has delivered mind-boggling returns for investors, generating multibagger returns of 1,800 per cent in just 1 year.

Today, shares of Remedium Lifecare Ltd hit 20 per cent upper circuit to Rs 700.10 per share from its previous closing of Rs 583.45. The stock’s 52-week high is Rs 898.30 and its 52-week low is Rs 35.31. The shares of the company saw a spurt in volume by more than 3 times on BSE. 

The sudden rise in the stock price was due to the company announcing stellar Quarterly Results (Q3FY24), nine-month results (9MFY24) and a stock split. Details below: -

The company experienced significant growth across all financial periods. In Q3FY24, net sales surged by 939 per cent and net profit skyrocketed by 4,425 per cent compared to Q3FY23. Similarly, in 9MFY24, net sales increased by 506 per cent and net profit grew by 747 per cent year-over-year. While the growth slowed down in FY23, net sales still managed to increase by 1 per cent and net profit rose by a remarkable 400 per cent compared to FY22.

Additionally, the Board of Directors of the company has approved and recommended for sub-division of the company's 1 (one) equity share of face value of Rs 5 each into 5 (five) equity shares of face value of Rs 1 each held as of the record date. The company fixed the record date for the stock split as Friday, February 23, 2024.

DSIJ offers a service 'Technical Advisory Services' with recommendations for best swing trading stocks based on research and analysis to help subscribers make healthy profits. If this interests you, then do download the service details pdf here

Remedium Lifecare Ltd is in the business of trading in advanced pharmaceutical intermediates and other pharma products. The company has a market cap of over Rs 1,400 crore with a 3-year stock price CAGR of 300 per cent.

The shares of the company have an ROE of 71 per cent and a ROCE of 103 per cent. The stock has delivered mind-boggling returns for investors, generating multibagger returns of 1,800 per cent in just 1 year, 8,850 per cent in 3 years, and a whopping 25,000 per cent in 5 years. Investors should keep an eye on this micro-cap stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

For more such updates on the go, Click here to join our WhatsApp Channel

Previous Article Heavy buying: Back-to-back upper circuit in this multibagger penny stock; emerging as a leading gold refinery plant in Zambia with daily revenue target of Rs 2.5 to 3.5 crore!
Next Article Multibagger mutual fund: This thematic fund has delivered 100 per cent return in just one year!
Print
10900 Rate this article:
3.7
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR